BioRestorative Therapies, Inc.
BRTX
$0.19
$0.00-1.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.24M | -12.67M | -10.72M | -12.10M | -8.98M |
| Total Depreciation and Amortization | 209.90K | 207.50K | 203.20K | 198.20K | 189.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.93M | 1.24M | 630.90K | 2.73M | 531.30K |
| Change in Net Operating Assets | 1.31M | 502.70K | 369.50K | 473.20K | 28.70K |
| Cash from Operations | -10.79M | -10.72M | -9.52M | -8.69M | -8.23M |
| Capital Expenditure | -116.10K | -48.80K | -107.30K | -142.60K | -106.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.01M | 8.08M | 7.08M | 7.95M | 620.70K |
| Cash from Investing | 8.90M | 8.03M | 6.97M | 7.81M | 514.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -144.40K | 33.60K | -39.20K | -33.60K | -- |
| Issuance of Common Stock | 5.19M | 4.70M | 4.70M | 2.81M | 8.12M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -387.30K | -965.90K | -794.50K | -692.10K | -744.00K |
| Cash from Financing | 2.85M | 1.81M | 1.85M | 953.60K | 7.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 963.30K | -887.00K | -697.00K | 71.70K | -336.50K |